| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.08B | 57.28B | 61.57B | 59.70B | 58.68B | 48.75B |
| Gross Profit | 9.34B | 8.97B | 8.47B | 6.51B | 8.35B | 6.50B |
| EBITDA | 7.77B | 5.91B | 6.29B | 3.63B | 3.29B | 4.66B |
| Net Income | 2.89B | 1.25B | 1.27B | -418.00M | -951.00M | 244.00M |
Balance Sheet | ||||||
| Total Assets | 81.36B | 82.00B | 80.14B | 74.48B | 73.31B | 74.85B |
| Cash, Cash Equivalents and Short-Term Investments | 12.08B | 11.50B | 10.65B | 8.41B | 8.85B | 10.58B |
| Total Debt | 13.82B | 14.04B | 16.24B | 13.82B | 13.40B | 13.19B |
| Total Liabilities | 38.26B | 40.26B | 40.11B | 37.41B | 36.57B | 36.49B |
| Stockholders Equity | 43.10B | 41.73B | 40.03B | 36.86B | 36.33B | 37.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.94B | 1.93B | -171.00M | -1.15B | -478.00M |
| Operating Cash Flow | 0.00 | 6.15B | 4.88B | 2.81B | 3.50B | 3.10B |
| Investing Cash Flow | 0.00 | -2.73B | -3.08B | -2.80B | -4.70B | -3.30B |
| Financing Cash Flow | 0.00 | -2.84B | 292.00M | -686.00M | -675.00M | 1.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥15.60B | 15.61 | ― | 3.41% | -3.27% | 572.42% | |
74 Outperform | ¥15.35B | 7.89 | ― | 1.17% | 53.68% | 146.92% | |
69 Neutral | ¥72.33B | 10.78 | 7.00% | 3.02% | 15.78% | ― | |
67 Neutral | ¥7.62B | 3.03 | ― | 1.37% | -3.05% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥28.03B | -53.89 | ― | 3.56% | -3.85% | -45.64% | |
59 Neutral | ¥31.44B | 4.17 | ― | 2.13% | 1.13% | -66.14% |